| Each
month The Savvy Investor analysts study, research, and examine
hundreds of stocks, in an effort to pinpoint the one with
the most promise.
Special Edition Pick : TDS Telemedicine, Inc.
Symbol: TDST
Recent
Trading Range: $.10
Opinion: Strong
Buy
|
| In
Related News: |
 |
 Health
care providers are getting wired up for a future where every
patient's medical record is a click away and doctors assist
one another in operations thousands of miles apart via video
conferencing. More...
 A
new approach to healthcare around the globe is on its way,
according to experts at the World Economic Forum.. More....
 TDS
Telemedicine CEO Roger Coomber and Chief Medical Officer
Keith Freeman Interviewed.  Video
|
Financial
Analysis
|
 |
|
With
funding approval in place, as well as anticipated additional
equity funding over the next few months, TDS expects the
following financial performance:
2003 Revenues $1.0 million
Net Pre-tax $100,000
2004 Revenues $13.5 million
Net Pre-tax $3.4 million
2005 Revenues $22.0 million
Net Pre-tax $6.25 million
Pechala's reports indicate
TDST stock
will appreciate +35% for the next 2-week
period. (see
PDF)
|
|
| Corporate
Snapshot |
 |
|
TDS Telemedicine Inc is the
parent Company of an established UK based firm,
TDS Dermatology Ltd. For the past 5 years this
Company has provided comprehensive dermatology
telemedicine to the National Health Service in
England. Over 25,000 telemedical
consultations have been performed since the Company
commenced operations, making it the world's largest
telemedical dermatology provider.
Now utilizing
telemedical technology, a single health care
professional can see multiple patients in almost any
location, even in the patients' homes. This means
maximum productivity for medical personnel, lower
capital expenses for the companies that employ them
and the added convenience of "house calls" for the
patients. Initially, TDS services will go live in
Texas. Discussions have commenced in other US states
and TDST's nationwide roll-out program will
go into effect quickly.
|
|
 |
|
Analyst Conclusion
The
recent SEC ruling to leave the Over The Counter Bulletin
Board in its current form is a very bullish sign for
this market - possibly a turning point. We think that
this is an encouraging signal from regulators that the
OTCBB can expect a more positive financial climate going
forward. We assessed TDST bearing these 3 basic
investment criteria in mind:
1. TDST is in a leading
Group.
Chart
2. The company financials are strong.
3. The overall market is in a confirmed rally.
I
would expect great things from this company and in my
opinion it is a Strong Buy.
 Editing
Chairman
|
|
